Transcobalamin I: a novel prognostic biomarker of neoadjuvant chemotherapy in locally advanced hypopharyngeal squamous cell cancers

BACKGROUND: Hypopharyngeal squamous cell carcinoma (HPSCC) is an aggressive head and neck squamous cell carcinoma with poor prognosis. Neoadjuvant chemotherapy (NACT) followed by concurrent chemoradiotherapy could provide better efficacy in HPSCC treatment. Identification of predictive biomarkers is...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Ying, Yue, Changli, Fang, Jugao, Gong, Lili, Lian, Meng, Wang, Ru, Feng, Ling, Ma, Hongzhi, Ma, Zhihong, Liu, Honggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065467/
https://www.ncbi.nlm.nih.gov/pubmed/30100732
http://dx.doi.org/10.2147/OTT.S166514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6065467/
https://www.ncbi.nlm.nih.gov/pubmed/30100732
http://dx.doi.org/10.2147/OTT.S166514

Ejemplares similares